These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31198893)

  • 1. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 2. [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options].
    Cursiefen C; Seitz B; Dana MR; Streilein JW
    Ophthalmologe; 2003 Apr; 100(4):292-9. PubMed ID: 12682761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-based antiangiogenic applications for corneal neovascularization.
    Liu S; Romano V; Steger B; Kaye SB; Hamill KJ; Willoughby CE
    Surv Ophthalmol; 2018; 63(2):193-213. PubMed ID: 29080632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Available Therapeutic Options for Corneal Neovascularization: A Review.
    Drzyzga Ł; Śpiewak D; Dorecka M; Wyględowska-Promieńska D
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of corneal neovascularization prior to corneal transplantation: Report of 112 cases].
    Belghmaidi S; Hajji I; Ennassiri W; Benhaddou R; Baha Ali T; Moutaouakil A
    J Fr Ophtalmol; 2016 Jun; 39(6):515-20. PubMed ID: 27324233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].
    Cursiefen C; Wenkel H; Martus P; Langenbucher A; Seitz B; Küchle M
    Klin Monbl Augenheilkd; 2001 Jul; 218(7):484-91. PubMed ID: 11512248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory corneal neovascularization: etiopathogenesis.
    Clements JL; Dana R
    Semin Ophthalmol; 2011; 26(4-5):235-45. PubMed ID: 21958169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
    Lu Y; Zheng Y; Ai J; Xu X
    Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Horizons in therapy for corneal angiogenesis.
    Maddula S; Davis DK; Maddula S; Burrow MK; Ambati BK
    Ophthalmology; 2011 Mar; 118(3):591-9. PubMed ID: 21376242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
    Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
    Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal neovascularization.
    Nicholas MP; Mysore N
    Exp Eye Res; 2021 Jan; 202():108363. PubMed ID: 33221371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model.
    Mirabelli P; Peebo BB; Xeroudaki M; Koulikovska M; Lagali N
    Exp Eye Res; 2014 Aug; 125():118-27. PubMed ID: 24933712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor in a recipient cornea acts as a prognostic factor for corneal graft reaction development.
    Sekelj S; Dekaris I; Balog T; Mahovne I; Krstonijevic EK; Janjetovic Z; Arar ZV; Aric I
    Curr Eye Res; 2015 Apr; 40(4):407-14. PubMed ID: 24912114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal transparency: genesis, maintenance and dysfunction.
    Qazi Y; Wong G; Monson B; Stringham J; Ambati BK
    Brain Res Bull; 2010 Feb; 81(2-3):198-210. PubMed ID: 19481138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
    Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
    Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and emerging therapies for corneal neovascularization.
    Roshandel D; Eslani M; Baradaran-Rafii A; Cheung AY; Kurji K; Jabbehdari S; Maiz A; Jalali S; Djalilian AR; Holland EJ
    Ocul Surf; 2018 Oct; 16(4):398-414. PubMed ID: 29908870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal neovascularization and biological therapy.
    Voiculescu OB; Voinea LM; Alexandrescu C
    J Med Life; 2015; 8(4):444-8. PubMed ID: 26664467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S; Peters S; Müther P; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.
    Giménez F; Suryawanshi A; Rouse BT
    Prog Retin Eye Res; 2013 Mar; 33():1-9. PubMed ID: 22892644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.